MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/art.70108

Медицинская библиотека · Arthritis & rheumatology (Hoboken, N.J.) · 2026

PEPITEM Regulates the Synovial Microenvironment During Immune-Mediated Inflammatory Arthritis to Limit Disease.

Wahid Mussarat, Kemble Samuel, Abudu Oladimeji, Saviano Anella, Mahony Christopher, Lewis Jonathan W, Nicholson Thomas A, Schettino Anna, Marigliano Noemi, Frost Kathryn, Begum Jenefa, Urbanowski Alyssa M, Limo Marion, Jha Rakesh, Jarquin Sandra Martinez, Pezhman Laleh, Degan Abbie E A, Anderson Amy E, Smith Charlotte G, Batki Armaiti, Adams Holly, Caso Francesco, Scarpa Raffaele, McInnes Iain, Siebert Stefan, Pratt Arthur G, Filer Andrew, Raza Karim, Croft Adam P, Chimen Myriam, de Cogan Felicity, Rainger G Ed, Iqbal Asif J, Maione Francesco, McGettrick Helen M

СтатьяПеревод в очереди

Аннотация

OBJECTIVE

Here we investigate the status of the adiponectin-PEPITEM pathway in early, treatment naive rheumatoid arthritis (RA) and psoriatic arthritis (PsA) and the therapeutic efficacy of PEPITEM administration in preclinical models.

METHODS

Peripheral blood was isolated from patients with clinical suspect arthralgia and suspected inflammatory arthritis and analyzed by flow cytometry or Western blot. Effect of PEPITEM treatment on inflammatory arthritis was assessed in mice by histology, single-cell RNA sequencing, flow cytometry, or multiplex analysis.

RESULTS

Patients newly diagnosed with RA and PsA had significantly reduced expression of adiponectin receptor 2 and its downstream signaling adapter protein APPL-1 on their peripheral-blood mononuclear cells, resulting in diminished response to adiponectin and local synovial concentrations of PEPITEM. Building on these observations, treatment with PEPITEM in three distinct inflammatory arthritis animal models significantly reduced arthritis severity, joint swelling, leukocyte infiltration, and expression of several pro-inflammatory mediators (eg, JE [CCL2], RANTES, interleukin-16) in the synovium. Mechanistically, PEPITEM treatment suppressed the cyclooxygenase 2 and NF-κB signaling pathways. Moreover, PEPITEM altered the composition of leukocyte subsets recruited into the joint.

CONCLUSION

Collectively, these findings underscore the importance of understanding the dysregulation of the adiponectin-PEPITEM pathway in different immune-mediated inflammatory diseases (IMIDs), such as RA and PsA. The observed differences in expression and downstream signaling through adiponectin receptors suggest potential targets for therapeutic intervention to restore the balance of this regulatory pathway to mitigate chronic inflammation and disease progression in these patients, paving the way for its clinical use as an alternative and/or combination therapy for early IMIDs.

Для цитирования: Wahid Mussarat, Kemble Samuel, Abudu Oladimeji, Saviano Anella, Mahony Christopher, Lewis Jonathan W, Nicholson Thomas A, Schettino Anna, Marigliano Noemi, Frost Kathryn, Begum Jenefa, Urbanowski Alyssa M, Limo Marion, Jha Rakesh, Jarquin Sandra Martinez, Pezhman Laleh, Degan Abbie E A, Anderson Amy E, Smith Charlotte G, Batki Armaiti, Adams Holly, Caso Francesco, Scarpa Raffaele, McInnes Iain, Siebert Stefan, Pratt Arthur G, Filer Andrew, Raza Karim, Croft Adam P, Chimen Myriam, de Cogan Felicity, Rainger G Ed, Iqbal Asif J, Maione Francesco, McGettrick Helen M. PEPITEM Regulates the Synovial Microenvironment During Immune-Mediated Inflammatory Arthritis to Limit Disease.. Arthritis & rheumatology (Hoboken, N.J.). 2026. DOI: 10.1002/art.70108.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.